Transcriptional Profiling of the Circulating Immune Response to Lassa Virus in an Aerosol Model of Exposure

PLoS Neglected Tropical Diseases

Volumn 7, Issue 4, 2013, Pages

  Malhotra, Shikha ^a   Yen, Judy Y ^a   Honko, Anna N ^b   Garamszegi, Sara ^a,c   Caballero, Ignacio S ^a,c   Johnson, Joshua C ^b   Mucker, Eric M ^b   Trefry, John C ^b   Hensley, Lisa E ^b,d   Connor, John H ^a,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c BOSTON UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 23P19; INTERLEUKIN 27; INTERLEUKIN 6; INTERLEUKIN 8; METALLOPROTEINASE; STAT1 PROTEIN; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; IMMUNE RESPONSE; LASSA VIRUS; MICROARRAY ANALYSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEIZURE; SIGNAL TRANSDUCTION; UPREGULATION; VIREMIA;

EID: 84876886135     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002171     Document Type: Article

References (58)

1. McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES, (1987) A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis 155: 437-444.
2. Fisher-Hoch SP, Tomori O, Nasidi A, Perez-Oronoz GI, Fakile Y, et al. (1995) Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ 311: 857-859.
3. Winn WC Jr, Walker DH, (1975) The pathology of human Lassa fever. Bull World Health Organ 52: 535-545.
4. Hensley LE, Smith MA, Geisbert JB, Fritz EA, Daddario-DiCaprio KM, et al. (2011) Pathogenesis of Lassa fever in cynomolgus macaques. Virol J 8: 205.
5. Monath TP, Newhouse VF, Kemp GE, Setzer HW, Cacciapuoti A, (1974) Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science 185: 263-265.
6. Keenlyside RA, McCormick JB, Webb PA, Smith E, Elliott L, et al. (1983) Case-control study of Mastomys natalensis and humans in Lassa virus-infected households in Sierra Leone. Am J Trop Med Hyg 32: 829-837.
7. Stephenson EH, Larson EW, Dominik JW, (1984) Effect of environmental factors on aerosol-induced Lassa virus infection. J Med Virol 14: 295-303.
8. Geisbert TW, Jahrling PB, (2004) Exotic emerging viral diseases: progress and challenges. Nat Med 10: S110-121.
9. McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, et al. (1986) Lassa fever. Effective therapy with ribavirin. N Engl J Med 314: 20-26.
10. Hadi CM, Goba A, Khan SH, Bangura J, Sankoh M, et al. (2010) Ribavirin for Lassa fever postexposure prophylaxis. Emerg Infect Dis 16: 2009-2011.
11. Flatz L, Rieger T, Merkler D, Bergthaler A, Regen T, et al. (2010) T cell-dependence of Lassa fever pathogenesis. PLoS Pathog 6: e1000836.
12. Yun NE, Poussard AL, Seregin AV, Walker AG, Smith JK, et al. (2012) Functional interferon system is required for clearance of lassa virus. J Virol 86: 3389-3392.
13. Jahrling PB, Smith S, Hesse RA, Rhoderick JB, (1982) Pathogenesis of Lassa virus infection in guinea pigs. Infect Immun 37: 771-778.
14. Walker DH, Murphy FA, (1987) Pathology and pathogenesis of arenavirus infections. Curr Top Microbiol Immunol 133: 89-113.
15. Jahrling PB, Hesse RA, Eddy GA, Johnson KM, Callis RT, et al. (1980) Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. J Infect Dis 141: 580-589.
16. Jahrling PB, Peters CJ, (1984) Passive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strain. Infect Immun 44: 528-533.
17. Jahrling PB, Peters CJ, Stephen EL, (1984) Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys. J Infect Dis 149: 420-427.
18. Evseev AA, Dvoretskaia VI, Bogatikov GV, Pshenichnov VA, Mustafin RM, (1991) [Experimental Lassa fever in hamadryas baboons]. Vopr Virusol 36: 150-152.
19. Carrion R Jr, Brasky K, Mansfield K, Johnson C, Gonzales M, et al. (2007) Lassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissues. J Virol 81: 6482-6490.
20. Lukashevich IS, Carrion R Jr, Salvato MS, Mansfield K, Brasky K, et al. (2008) Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates. Vaccine 26: 5246-5254.
21. Baize S, Marianneau P, Loth P, Reynard S, Journeaux A, et al. (2009) Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys. J Virol 83: 5890-5903.
22. Walker DH, Wulff H, Lange JV, Murphy FA, (1975) Comparative pathology of Lassa virus infection in monkeys, guinea-pigs, and Mastomys natalensis. Bull World Health Organ 52: 523-534.
23. Peters CJ, Jahrling PB, Liu CT, Kenyon RH, McKee KT Jr, et al. (1987) Experimental studies of arenaviral hemorrhagic fevers. Curr Top Microbiol Immunol 134: 5-68.
24. Yen JY, Garamszegi S, Geisbert JB, Rubins KH, Geisbert TW, et al. (2011) Therapeutics of Ebola hemorrhagic fever: whole-genome transcriptional analysis of successful disease mitigation. J Infect Dis 204 (Suppl 3) (): S1043-1052.
25. R Core Development Team (2012) R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
26. de Hoon MJ, Imoto S, Nolan J, Miyano S, (2004) Open source clustering software. Bioinformatics 20: 1453-1454.
27. Saldanha AJ, (2004) Java Treeview-extensible visualization of microarray data. Bioinformatics 20: 3246-3248.
28. Huang W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
29. Trombley AR, Wachter L, Garrison J, Buckley-Beason VA, Jahrling J, et al. (2010) Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. Am J Trop Med Hyg 82: 954-960.
30. Grandvaux N, Servant MJ, tenOever B, Sen GC, Balachandran S, et al. (2002) Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J Virol 76: 5532-5539.
31. Ibekwe T, (2012) Lassa fever: the challenges of curtailing a deadly disease. Pan Afr Med J 11: 55.
32. Cilloniz C, Ebihara H, Ni C, Neumann G, Korth MJ, et al. (2011) Functional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection. J Virol 85: 9060-9068.
33. Mahanty S, Bausch DG, Thomas RL, Goba A, Bah A, et al. (2001) Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever. J Infect Dis 183: 1713-1721.
34. Djavani MM, Crasta OR, Zapata JC, Fei Z, Folkerts O, et al. (2007) Early blood profiles of virus infection in a monkey model for Lassa fever. J Virol 81: 7960-7973.
35. Schmitz H, Kohler B, Laue T, Drosten C, Veldkamp PJ, et al. (2002) Monitoring of clinical and laboratory data in two cases of imported Lassa fever. Microbes Infect 4: 43-50.
36. Elsaesser H, Sauer K, Brooks DG, (2009) IL-21 is required to control chronic viral infection. Science 324: 1569-1572.
37. Galligan CL, Matsuyama W, Matsukawa A, Mizuta H, Hodge DR, et al. (2004) Upregulated expression and activation of the orphan chemokine receptor, CCRL2, in rheumatoid arthritis. Arthritis Rheum 50: 1806-1814.
38. Hayes MW, Carrion R Jr, Nunneley J, Medvedev AE, Salvato MS, et al. (2012) Pathogenic Old World arenaviruses inhibit TLR2/Mal-dependent proinflammatory cytokines in vitro. J Virol 86: 7216-7226.
39. Amarnath S, Mangus CW, Wang JC, Wei F, He A, et al. (2011) The PDL1-PD1 axis converts human TH1 cells into regulatory T cells. Sci Transl Med 3: 111ra120.
40. Liu J, Na S, Glasebrook A, Fox N, Solenberg PJ, et al. (2001) Enhanced CD4+ T cell proliferation and Th2 cytokine production in DR6-deficient mice. Immunity 15: 23-34.
41. Mashima R, Hishida Y, Tezuka T, Yamanashi Y, (2009) The roles of Dok family adapters in immunoreceptor signaling. Immunol Rev 232: 273-285.
42. Senis YA, Antrobus R, Severin S, Parguina AF, Rosa I, et al. (2009) Proteomic analysis of integrin alphaIIbbeta3 outside-in signaling reveals Src-kinase-independent phosphorylation of Dok-1 and Dok-3 leading to SHIP-1 interactions. J Thromb Haemost 7: 1718-1726.
43. Ligresti G, Aplin AC, Dunn BE, Morishita A, Nicosia RF, (2012) The acute phase reactant orosomucoid-1 is a bimodal regulator of angiogenesis with time- and context-dependent inhibitory and stimulatory properties. PLoS One 7: e41387.
44. Welsby I, Hutin D, Leo O, (2012) Complex roles of members of the ADP-ribosyl transferase super family in immune defences: looking beyond PARP1. Biochem Pharmacol 84: 11-20.
45. Joo M, Sadikot RT, (2012) PGD synthase and PGD2 in immune resposne. Mediators Inflamm 2012: 503128.
46. Gong D, Farley K, White M, Hartshorn KL, Benarafa C, et al. (2011) Critical role of serpinB1 in regulating inflammatory responses in pulmonary influenza infection. J Infect Dis 204: 592-600.
47. Scott EP, Aronson JF, (2008) Cytokine patterns in a comparative model of arenavirus haemorrhagic fever in guinea pigs. J Gen Virol 89: 2569-2579.
48. Baize S, Kaplon J, Faure C, Pannetier D, Georges-Courbot MC, et al. (2004) Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J Immunol 172: 2861-2869.
49. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, et al. (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133.
50. Hegde S, Pahne J, Smola-Hess S, (2004) Novel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-kappaB binding activity and CCR7 expression. FASEB J 18: 1439-1441.
51. Hahm B, Trifilo MJ, Zuniga EI, Oldstone MB, (2005) Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity 22: 247-257.
52. Dauer M, Pohl K, Obermaier B, Meskendahl T, Robe J, et al. (2003) Interferon-alpha disables dendritic cell precursors: dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and T-cell stimulation. Immunology 110: 38-47.
53. McNally JM, Zarozinski CC, Lin MY, Brehm MA, Chen HD, et al. (2001) Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses. J Virol 75: 5965-5976.
54. Bahl K, Kim SK, Calcagno C, Ghersi D, Puzone R, et al. (2006) IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections. J Immunol 176: 4284-4295.
55. Andersen KG, Shylakhter I, Tabrizi S, Grossman SR, Happi CT, et al. (2012) Genome-wide scans provide evidence for positive selection of genes implicated in Lassa fever. Philos Trans R Soc Lond B Biol Sci 367: 868-877.
56. Hirahara K, Ghoreschi K, Yang XP, Takahashi H, Laurence A, et al. (2012) Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1. Immunity 36: 1017-1030.
57. Rubins KH, Hensley LE, Wahl-Jensen V, Daddario DiCaprio KM, Young HA, et al. (2007) The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever. Genome Biol 8: R174.
58. Woods CW, McClain MT, Chen M, Zaas AK, Nicholson BP, et al. (2013) A Host Transcriptional Signature for Presymptomatic Detection of Infection in Humans Exposed to Influenza H1N1 or H3N2. PLoS One 8: e52198.